MedTrace Logo

Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin

NCT03820466 · Status: TERMINATED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 68

Last updated 2022-05-24

No results posted yet for this study

Summary

The study evaluates the effect of platelet inhibition and / or lipid lowering in non-ACS-patients with symptoms suggestive for ACS, and elevated high-sensitivity troponin values

Conditions

  • Acute Chest Syndrome

Interventions

DRUG

Aspirin

Once daily application of platelet inhibiting medication

DRUG

Atorvastatin

Once daily application of lipid lowering medication

DRUG

Placebo Aspirin

Once daily application of placebo

DRUG

Placebo Atorvastatin

Once daily application of placebo

Sponsors & Collaborators

  • Dr. med. Mahir Karakas

    lead OTHER

Principal Investigators

  • Mahir Karakas, MD · University Heart Center Hamburg

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-21
Primary Completion
2021-12-02
Completion
2022-04-07

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03820466 on ClinicalTrials.gov